NCT04652219View on ClinicalTrials.gov

CART Therapy in GUCY2C-positive Digestive Tract Tumors

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 10, 2020

Primary Completion Date

October 9, 2021

Study Completion Date

October 9, 2021

Conditions
Malignant Neoplasms of Digestive Organs
Interventions
BIOLOGICAL

gucy2c cart cells

Patients with advanced malignant gastrointestinal tumors were injected with CART cells

Trial Locations (1)

310006

First affiliated hospital, Zhejiang University, Hangzhou

Sponsors
All Listed Sponsors
collaborator

Innovative Cellular Therapeutics Co., Ltd.

OTHER

lead

Weijia Fang, MD

OTHER